Prashant P Deshpande

This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Astrazeneca Ab. Active years: 2008-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Prashant P Deshpande. Retrieved from https://idiyas.com/inventor/prashant-p-deshpande

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 4)

% Patents Active = 87.5

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 9.5

ph-index = 4

Forward Citations = 131(Granted Patents)

Company Filing History:

7 out of 3,742

Bristol-Myers Squibb Compnay

Years Active: 2008-2016

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9453039 - Crystal structures of SGLT2 inhibitors and processes for preparing same (2016-09-27),

2. 9249171 - Sulfilimine and sulphoxide methods for producing festinavir (2016-02-02),

3. 8501698 - Crystal structures of SGLT2 inhibitors and processes for preparing same (2013-08-06),

4. 7932379 - Methods of producing C-aryl glucoside SGLT2 inhibitors (2011-04-26),

5. 7919598 - Crystal structures of SGLT2 inhibitors and processes for preparing same (2011-04-05),

6. 7820820 - Method of preparation of azaindole derivatives (2010-10-26),

7. 7598380 - Method of preparation of azaindole derivatives (2009-10-06),

8. 7375213 - Methods of producing C-aryl glucoside SGLT2 inhibitors (2008-05-20),

Title: Prashant P Deshpande: Innovator in Pharmaceutical Chemistry

Introduction

Prashant P Deshpande is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds and processes. With a total of 8 patents to his name, Deshpande's work has had a substantial impact on the treatment of various diseases, including diabetes.

Latest Patents

Among his latest patents, Deshpande has developed crystal structures of SGLT2 inhibitors and processes for preparing them. This invention relates to the physical crystal structures of a compound, which includes pharmaceutical compositions and methods for treating diseases such as diabetes. Another significant patent involves the sulfilimine and sulfoxide methods for producing festinavir, which outlines a process for synthesizing the compound using specific starting materials and process steps.

Career Highlights

Deshpande has worked with prominent companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and AstraZeneca AB. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in drug formulation and synthesis.

Collaborations

Throughout his career, Deshpande has collaborated with talented individuals such as Chiajen Lai and Janak Singh. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.

Conclusion

Prashant P Deshpande is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the industry. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.